By M T
In this presentation at Cell and Gene Meeting on the MESA 2025, Tozaro’s CEO Jason Slingsby provided an update on the adoption of Smart PolymersTM in viral vector purification. Tune in for the next 15 minutes to learn: Watch now:
By M T
Jason Slingsby, CEO at Tozaro presents at Cell and Gene Meeting on the Med 2026. Watch this 15 minute presentation for an update on how Tozaro’s Smart PolymerTM Platform Technology is being used to design new affinity ligands for the purification of viral vectors. What you will learn: Watch now:
By M T
Presented by Alex Shephard at BioProcess International 2025 (BPI), this poster introduces Smart PolymersTM developed for the selective capture, release, and purification of lentiviral vectors. Read how the polymers were immobilized on a membrane and used to purify lentiviral samples via the AKTA FPLC. The work demonstrated recovery of >60% along with excellent purity profiles, … Continued
By M T
Originally published in International Biopharmaceutical Industry Journal, Volume 7, Issue 4. Tozaro’s Head of Cell and Gene Therapy Applications, Abdullah Sufan, discusses the latest trends shaping downstream processing and the technologies helping to make advanced therapies more affordable and scalable. This review explores the evolving landscape of viral vector purification, highlighting emerging approaches that can … Continued
By M T
Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 2, our host Alex Shephard chats with Giuliana Vallanti, SVP Operations and R&D at AGC Biologics. She discusses two decades in cell and gene therapy, from process … Continued
By M T
First presented at The Bioprocessing Summit 2026, this poster introduces a platform of synthetic Smart PolymersTM, rationally designed as affinity ligands for the selective capture, release, and purification of AAV and lentiviral vectors. These reagents are engineered to enable serotype-specific or pan-serotype binding, with tunable affinity for both purification and analytical use.
By M T
Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 1, our host Alex Shephard chats with Andre Raposo, Senior Director of Innovation about his journey from fundamental HIV research to leading innovation in viral vector manufacturing … Continued
By Keli
This research poster LC-MS Detection of SARS-Cov2 Spike Protein using Smart Polymers emphasises the possibility of using smart polymers for viral purification.
By Keli
3 new prototypes for the detection of in-tact lentivirus were made and evaluated in just 4 months. This shows that Tozaro’s smart polymer development process can be used for rapid generation of new reagents to support proprietary gene therapy manufacturing processes.
By Keli
First presented at The Bioprocessing Summit 2024, this poster introduces a new suite of synthetic affinity reagents targeting VSV-G, a lentivirus envelope protein for viral vector analytics and purification. Smart polymers targeting VSV-G accurately detect lentivirus in Octet® BLI platform and show promise for novel capture chromatography These synthetic affinity reagents have been designed to … Continued